| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |